10 October 2024
10 October 2024
SipNose's diverse range of devices are designed to target specific areas within the nasal cavity.
The funding is set to be used to launch a new a multi-centre, blinded, randomised clinical trial designed to test the ShiraTronic device.
The Happy Ring tracks vital health metrics such as sleep, blood oxygen, heart rate, temperature and brain activity.
Clearside is now looking at a Phase III trial as it plans to meet with the FDA early next year to discuss the new Phase IIb topline results.
The company is preparing to submit an application for US Food and Drug Administration (FDA) clearance to market the disposable kit.
Allurion has added more efficacy and safety data to support its intragastric balloon, but popularity of GLP-1 drugs shows no signs of slowing.
The pivotal trial aims to support the CE mark and FDA approval of 4C Medical’s AltaValve System.
The company plans to study the application of molecular residual disease (MRD) testing in breast cancer management using its Precise MRD test.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
